Ultragenyx Pharmaceutical Market Sentiment

Ultragenyx Pharmaceutical Inc

RARENASDAQ

Trade with Public

$14.90

-0.02-0.13%

마지막 업데이트: Oct 14, 7:38 PM

$14.71

-0.21-1.38%

개요 뉴스 실적 전망 이벤트 목표가 재무심리지분 현황 비교 옵션 주식 보고서

Ultragenyx Pharmaceutical Market Sentiment

Market sentiment signals for Ultragenyx Pharmaceutical (RARE): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▲ Buy

Short Interest▼ 21.4% short float

Options Flow▲ 0.15 P/C ratio

Insider Activity— N/A

Analyst Consensus

Buy

27 analysts

Options Flow (P/C)

0.15

More calls — Bullish

539 calls · 79 puts

Avg Consensus PT

$48

+226.2%

Highest Price Target

$140

+851.5%

Piper Sandler

Lowest Price Target

$16

+8.7%

Baird

Short Interest

21.4%

Rising — Bearish

Insider Activity (30d)

—

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Sep 21, 2026	Evercore ISI Group	Liisa Bayko—	+22.3%	$16 → $18	Maintained	In-Line
Sep 21, 2026	Barclays	Eliana Merle—	+137.9%	$32 → $35	Maintained	Overweight
Sep 18, 2026	Morgan Stanley	Maxwell Skor—	+35.9%	$18 → $20	Maintained	Equal-Weight
Sep 18, 2026	Citigroup	Yigal Nochomovitz—	+117.5%	$31 → $32	Maintained	Buy
Sep 18, 2026	Canaccord Genuity	Whitney Ijem—	+165.1%	$37 → $39	Maintained	Buy
Sep 18, 2026	Cantor Fitzgerald	Kristen Kluska—	+165.1%	$33 → $39	Maintained	Overweight
Sep 17, 2026	Citigroup	Yigal Nochomovitz—	+110.7%	$28 → $31	Maintained	Buy
Sep 4, 2026	Goldman Sachs	Salveen Richter—	+29.1%	$28 → $19	Maintained	Neutral
Sep 4, 2026	Barclays	Eliana Merle—	+117.5%	$43 → $32	Maintained	Overweight
Sep 3, 2026	JP Morgan	Anupam Rama—	+144.7%	$80 → $36	Downgrade	Overweight→Neutral
Sep 3, 2026	Jefferies	Maury Raycroft—	+90.3%	$77 → $28	Maintained	Buy
Sep 3, 2026	William Blair	Sami Corwin—	—	—	Downgrade	Outperform→Market Perform
Sep 3, 2026	Citigroup	Yigal Nochomovitz—	+90.3%	$58 → $28	Maintained	Buy
Sep 3, 2026	TD Cowen	Yaron Werber—	+22.3%	$49 → $18	Maintained	Buy
Sep 3, 2026	Wells Fargo	Benjamin Burnett—	+22.3%	$50 → $18	Maintained	Overweight
Sep 3, 2026	Canaccord Genuity	Whitney Ijem—	+151.5%	$83 → $37	Maintained	Buy
Sep 3, 2026	Wedbush	Laura Chico—	+56.3%	$30 → $23	Maintained	Neutral
Sep 3, 2026	Evercore ISI Group	Liisa Bayko—	+8.7%	$34 → $16	Downgrade	Outperform→In-Line
Sep 3, 2026	Baird	Joel Beatty—	+8.7%	$40 → $16	Downgrade	Outperform→Neutral
Sep 3, 2026	HC Wainwright & Co.	Raghuram Selvaraju—	+69.9%	$50 → $25	Maintained	Buy
Sep 3, 2026	Cantor Fitzgerald	Kristen Kluska—	+124.3%	$103 → $33	Maintained	Overweight
Aug 28, 2026	Wells Fargo	Michael Turrin—	+239.8%	$46 → $50	Maintained	Overweight
Aug 25, 2026	JP Morgan	Anupam Rama—	+443.7%	$75 → $80	Maintained	Overweight
Aug 21, 2026	Morgan Stanley	Jeffrey Hung—	+402.9%	$67 → $74	Maintained	Overweight
Aug 20, 2026	Canaccord Genuity	Whitney Ijem—	+464.1%	$81 → $83	Maintained	Buy